Skip to content

Shockwave IVL System with the Shockwave E8 Peripheral IVL Catheter E8IVL060080Recalls & reported problems

Shockwave Medical, Inc. · The IVL Catheter is a proprietary lithotripsy device delivered through the peripheral arterial system of the lower extremities to the site of an otherwise difficult to treat calcified stenosis. Energizing the lithotripsy device will generate acoustic pressure pulses within the target treatment site, disrupting calcium within the lesion and allowing subsequent dilation of a peripheral artery stenosis using low balloon pressure. The IVL Catheter is comprised of an integrated balloon with an array of integrated lithotripsy emitters for the localized delivery of acoustic pressure pulses. The system consists of an IVL Catheter, an IVL Connector Cable and an IVL Generator. The Shockwave E8 Peripheral IVL Catheter shaft contains an inflation lumen, a guidewire lumen, and the lithotripsy emitters. The emitters are positioned along the length of the balloon working length for delivery of acoustic pressure pulses. The balloon is located near the distal tip of the catheter. Two radiopaque marker bands within the balloon denote the length of the balloon to aid in positioning of the balloon during treatment. The balloon is designed to provide an expandable segment of known length and diameter at a specific pressure. The IVL Generator and Connector Cable are used with a Shockwave Medical IVL Catheter to deliver localized, lithotripsy-enhanced, balloon dilatation of calcified, stenotic arteries. The IVL Generator, IVL Connector Cable and IVL Catheters are designed to exchange data during patient treatment. · Class 2

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
2
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00195451000584), received between Feb 4, 2026 and Mar 30, 2026 — classified as 1 injury, 1 malfunction.

The most frequently reported specific device problem is “Detachment of Device or Device Component” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 1 reportsMar 2026: 1 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1
  • Detachment of Device or Device Component1
  • Difficult to Advance1

Patient problems

  • No Clinical Signs, Symptoms or Conditions1
  • Obstruction/Occlusion1

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • MalfunctionMar 30, 2026Detachment of Device or Device Component; Difficult to Advance

    A SHOCKWAVE E8 PERIPHERAL INTRAVASCULAR LITHOTRIPSY (IVL) CATHETER WAS USED TO TREAT A LESION IN THE COMMON FEMORAL ARTERY VIA CONTRALATERAL FEMORAL ACCESS. THERE WAS NO RESISTANCE WHILE ADVANCING THE CATHETER OVER THE GUIDEWIRE OR THROUGH THE SHEATH. HOWEVER, IT WAS REPORTED THAT SEVERE ILIAC TORTUOSITY AND THE PRESENCE OF PRIOR ILIAC STENTS LIMITED THE ABILITY TO ADVANCE THE CATHETER. THE DEVICE WAS ADVANCED ACROSS THE AORTIC BIFURCATION BUT COULD NOT REACH THE TARGET LESION IN THE COMMON FEMORAL ARTERY. DURING CATHETER REMOVAL, THE E8 SHAFT FRACTURED AND THE BALLOON DETACHED. ALL COMPONENTS WERE SUCCESSFULLY RETRIEVED, AND NO FRAGMENTS WERE RETAINED IN THE PATIENT. NO PATIENT HARM WAS REPORTED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 24722174 ↗
  • InjuryFeb 4, 2026Adverse Event Without Identified Device or Use Problem

    THIS EVENT WAS REPORTED FROM THE SHOCKWAVE DISRUPT PAD JAPAN STUDY. A SHOCKWAVE E8 PERIPHERAL INTRAVASCULAR LITHOTRIPSY (IVL) CATHETER WAS USED TO TREAT A LESION IN THE FEMOROPOPLITEAL ARTERY. THE FIRST IVL CATHETER USED BROKE WHILE ATTEMPTING TO INSERT THE DEVICE. THE DEVICE DID NOT ENTER THE PATIENT AND NO PULSES WERE DELIVERED. A SECOND SHOCKWAVE E8 PERIPHERAL IVL CATHETER WAS USED AND 400 IVL PULSES WERE SUCCESSFULLY DELIVERED TO THE TARGET LESION. FOUR DAYS POST-PROCEDURE, A SUPERFICIAL FEMORAL ARTERY (SFA) ACUTE OCCLUSION WAS OBSERVED, AND THE PATIENT WAS READMITTED TO THE HOSPITAL. THE PATIENT REPORTED SUDDEN NUMBNESS AND COLDNESS IN THE LEFT LOWER LEG. TWO DAYS LATER, THE PATIENT UNDERWENT THROMBECTOMY, AND TARGET LESION REVASCULARIZATION OF THE LEFT SFA, FOLLOWED BY A STENT PLACEMENT. THE PRINCIPAL INVESTIGATOR CONFIRMED THAT BLOOD FLOW TO THE LOWER LIMB IMPROVED SIGNIFICANTLY. THE PATIENT WAS DISCHARGED THREE DAYS AFTER. (THIS EVENT WAS PREVIOUSLY REPORTED VIA MDR# 3015053858-2025-00110.) ON (B)(6) 2026, FIVE (5) MONTHS POST INDEX PROCEDURE, THE PATIENT WAS ADMITTED TO THE HOSPITAL DUE TO A REPORT OF SUDDEN NUMBNESS AND A COLD SENSATION IN THE LOWER LEFT LEG. AN ANGIOGRAM

    Patient problems: Obstruction/Occlusion

    MAUDE report 24264441 ↗

Other Percutaneous Catheter, Ultrasound devices

All Percutaneous Catheter, Ultrasound devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page